GASTROESOPHAGEAL REFLUX DISEASE

 

GASTROESOPHAGEAL REFLUX DISEASE

 

DEFINITION:

The return of an abnormal quantity of gastric contents into the esophagus resulting in gastrointestinal, respiratory, and/or neurobehavioural manifestations.

EPIDEMIOLOGY:

  • incidence: ?
  • age of onset:
    • peak age from 1-4 months
  • provocative factors:
    • supine positioning
    • smoking
    • certain foods and medications (see Management)

PATHOGENESIS:

1. Background

1. Physiologic Regurgitant Reflux

  • all infants and children reflux occasionally
  • brief episodes of postprandial reflux is normal
  • must differentiate physiologic from pathogenic reflux

2. Pathogenic Regurgitant Reflux

  • differs from physiologic reflux in two ways:
  • 1. Quantity
    • abnormal quantity of reflux
      • increased frequency and/or duration of episodes
  • 2. Detrimental Effects
    • Gastrointestinal
    • Respiratory
    • Neurobehavioural
  • 2. Pathogenesis

    • a disturbance of the normal functioning of the esophagus and related structures results in defective antireflux barrier
    • 1. Gastric Dysfunction
      • increased volume of gastric contents
      • increased abdominal pressure (obesity, tight clothes)
    • 2. Lower Esophageal Sphincter (LES) Dysfunction
      • transient relaxation of LES (major cause of reflux)
      • basal relaxation of LES (minor cause of reflux)
    • 3. Esophageal Dysfunction
      • impaired esophageal clearance of refluxate

    CLINICAL FEATURES:

    1. Infants

    1. Gastrointestinal Manifestations

    • failure to thrive
    • malnutrition
    • esophagitis
      • feeding problems
      • irritability
      • hematemesis
      • anemia

    2. Respiratory Manifestations

    • apnea (obstructive)
    • chronic cough
    • wheeze
    • pneumonia (chronic or recurrent)
    • cyanotic spells
    • others - stridor, hiccups, hoarseness
    • reflux with respiratory complications are more likely to be observed in association with certain disorders in both infants and children, i.e., esophageal atresia, Cystic Fibrosis, Bronchopulmonary Dysplasia, Tracheoesophageal
    • Fistula

    3. Neurobehavioural Manifestations

    • arching and stiffening
    • hyperextenstion of the neck or markedly flexed to one side (torticollis of Sandifer Syndrome)

    2. Children/Adolescence

    1. Gastrointestinal Manifestations (Esophagitis)

    • chest pain (heartburn [pyrosis])
    • dysphagia (difficult swallowing)
    • hallitosis (refluxate in mouth)
    • odynophagia (painful swallowing)
    • waterbrush (flow of salty saliva into mouth)
    • hematemesis
    • anemia (iron-deficient)

    2. Respiratory Manifestations

    • recurrent or chronic pneumonias
    • recurrent wheeze
    • chronic cough
    • others - stridor, hoarseness

    INVESTIGATIONS:

    1. pH Monitering

    • placement of a pH probe into the distal esophagus to moniter the total time that there is acid (pH <4) in the distal esophagus
    • considered the "gold standard" for the diagnosis of pathogenic reflux
    • quantifies the frequency and duration of acid reflux for prolonged periods
    • detects a temporal relationship between episodes of reflux and discrete signs and symptoms (neurobehavioural manifestations)
    • identifies "at risk" conditions, i.e., sleeping, coughing
    • limitations:
      • cannot detect nonacid reflux
      • 24 hours in duration
      • limited availability

    2. Scintigraphic Monitering

    • adding of radiolabelled (technetium 99m sulfer colloid) to feed
    • detects postprandial reflux and gastric emptying

    3. Barium Esophagram/Upper GI Fluoroscopy

    • performed following a barium meal
    • provides a crude quantification of the frequency and duration of reflux
    • less sensitive for aspiration reflux
    • rules out structural and functional anomalies fo the upper GI tract, i.e., strictures, hiatal hernias, pyloric stenosis, etc.

    4. Endoscopy +/- Esophageal Biopsy

    • detects esophagitis (erosions, ulcerations), strictures, gastric peptic disease

    5. Esophageal Manometry

    • detects specific motility anomalies and low LES pressure
    • does not detect reflux

    6. Chest X-Ray

    • aspiration and/or recurrent pneumonias

    MANAGEMENT:

    I. APPROACH

  • 1. Diagnosis
  • 2. Education
  • 3. Goals of Therapy
  • 4. Treatment Options
  • 5. Management Strategies
  • 1. Conservative
  • 2. Pharmacologic
  • 1. Prokinetic
  • 2. Acid-Reducing
  • 3. Barrier
  • 3. Surgical
  • 1. Diagnosis

    • based on history, physical, and investigations

    2. Education

    • discuss diagnosis with parents and explain physiologic from pathogenic reflux

    3. Goals of Therapy

    • to eliminate the detrimental effects of reflux - gastrointestinal, respiratory, and/or neurobehavioural manifestations

    4. Treatment Options

    1. No Therapy

    • 60-65% of infants with severe reflux will be asymptomatic without therapy by 2 years of age

    2. Therapy

    • see below

    5. Management Strategies

    1. Conservative

  • 1. Position
    • place in prone or upright positions
    • avoid supine or semiseated position
    • head of bed elevation may be useful
  • 2. Feeding
    • thicken infant feedings (1 tablespoon of dry rice cereal/oz. formula)
    • fast before sleeping
    • avoid large meals (smaller but more frequent feeds)
    • diet if overweight or obese
    • avoid foods that decrease the LES pressure or increase gastric acidity
      • alcohol - coffee
      • carbonated drinks - fatty foods
      • citrus fruits - tomatoes
  • 3. Avoidance
    • avoid tight fitting clothes
    • avoid tobacco smoke
    • avoid medications that decrease the LES pressure or increase gastric acidity
      • adrenergics
      • anticholinergics
      • calcium-channel blockers
      • prostaglandins
      • xanthines (caffeine, theophylline)
  • 2. Pharmacologic

  • 1. Prokinetic Agents
    • mechanism of action: act to raise the basal LES pressure, improve esophageal clearance, increase rate of gastric emptying
    • trial of 8 weeks
    • 1. Cisapride
      • 0.3 mg/kg/dose po tid to be given before meals
      • noncholinergic, nonantidopaminergic agent that increases postganglionic acetylcholine release
    • 2. Others
      • Cholinergic Agonists (Bethanechol)
      • Dopamine Antagonists (Domperidone)
        • may be used as a first line therapy
        • 5 mg po qid (before feeds)
  • 2. Acid-Reducing Agents
    • tend to use in older patients with pain associated with esophagitis
    • 1. Histamine Antagonists
    • 1. Cimetidine (Tagamet)
      • 5-10 mg/kg/dose po qid
    • 2. Ranitidine (Zantac)
      • 2 mg/kg/dose po tid
    • 2. Antacids
      • 0.5-1.0 mm3/kg/dose po 3-8x/day
  • 3. Barrier Agents
  • 1. Sulcralfate
    • mechanism of action: coats damaged mucosa, inhibits pepsin activity, adsorbs bile salts
    • 1 gm in 5-15cc solution po qid
    • used rarely in children
  •  

    3. Surgery

  • 1. Indications
    • failure of medical management
      • severe or intractable detrimental effects, i.e., failure to thrive, recurrent pneumonias
    • peptic strictures
    • neurologically-impaired children +/- G-tube
  • 2. Nissen Fundoplication +/- G-Tube Insertion
    • surgery acts to increase LES pressure
    • 90% success rate
    • complications:
  • 1. Short Term
    • herniation of wrap through the hiatus
    • small bowel obstruction due to adhesions
    • intraperitoneal leakage
  • 2. Long Term
    • inability to burp (gas bloat)
    • inability to vomit when necessary
    • dysphagia
    • loosening of wrap
  • 6. Prognosis

    1. Infants

  • 1. Mild/Moderate Reflux
    • majority symptom-free and able to discontinue medical therapy by 1 year of age
  • 2. Severe Reflux
    • 60-65% asymptomatic without therapy by 2 years of age
  • 2. Children

    • more resistant to complete resolution with good response to medical therapy but relapse when discontinued

    INTERNET LINKS:

    Pediatric/Adolescent Gastroesophageal Reflux Association (PAGER)
    CSMC NICU Teaching Files: GER
    Gastroesophageal Reflux in Infants

     

     

     

    Pediatric Database - GASTROESOPHAGEAL REFLUX DISEASE

    Pediatric Organization - Pedbase [at] Gmail.com